Drug Metabolism – Definition and Basics

What is Drug Metabolism?

Drug metabolism (also referred to as drug biotransformation or pharmaceutical metabolism) is the biochemical process by which the body chemically alters medicinal substances. It is a core component of pharmacology and plays a central role in determining how a drug works, how long it remains active in the body, and how it is ultimately eliminated. Drug metabolism falls under the broader discipline of pharmacokinetics, which describes what the body does to a drug after administration.

Primary Sites of Drug Metabolism

While drug metabolism can occur throughout the body, the liver is the primary organ responsible. Other contributing sites include:

• Liver: The main metabolic organ; contains the highest concentration of drug-metabolizing enzymes.
• Small intestine: Contributes to drug breakdown during absorption, known as the first-pass effect.
• Kidneys: Involved in the excretion of metabolites.
• Lungs, skin, and blood plasma: Play minor but relevant roles in metabolizing certain substances.

Phases of Drug Metabolism

Drug metabolism is classically divided into two main phases:

Phase I Reactions

Phase I reactions involve chemical modifications such as oxidation, reduction, or hydrolysis. These reactions introduce or expose functional groups on the drug molecule, making it more polar and water-soluble. The most important enzymes in this phase are the Cytochrome P450 enzymes (CYP enzymes), a superfamily of liver enzymes responsible for metabolizing the majority of clinically used drugs.

Phase II Reactions

Phase II reactions involve the conjugation of Phase I metabolites (or sometimes the parent drug directly) with endogenous molecules such as glucuronic acid, sulfate, or glutathione. This significantly increases water solubility, facilitating excretion via the kidneys or bile. Common Phase II reactions include glucuronidation, sulfation, and acetylation.

Cytochrome P450 Enzymes and Their Significance

The CYP enzyme family is central to drug metabolism. The most clinically relevant isoforms include CYP3A4, CYP2D6, CYP2C9, and CYP2C19, which together are responsible for the metabolism of a large proportion of all marketed medications. Genetic differences in these enzymes help explain why patients may respond differently to the same drug.

Related Pharmacokinetic Concepts

First-Pass Effect

When a drug is taken orally, it passes through the gut wall and into the portal vein before reaching systemic circulation. During this transit through the liver, a significant proportion of the drug may be metabolized before it ever reaches its target tissue. This process is known as the first-pass effect (or presystemic elimination) and directly impacts a drug's bioavailability.

Prodrugs

Some drugs are intentionally designed as prodrugs -- pharmacologically inactive compounds that are converted into their active form through metabolic processes in the body. A well-known example is codeine, which is metabolized in the liver to morphine, its active metabolite.

Half-Life

The half-life of a drug refers to the time required for the plasma concentration of the drug to decrease by half. It is directly influenced by the rate of metabolism and excretion and is a key factor in determining appropriate dosing intervals.

Factors Influencing Drug Metabolism

Numerous factors can significantly alter the rate and extent of drug metabolism:

• Genetics (Pharmacogenetics): Genetic variants in CYP enzymes can classify individuals as poor, intermediate, extensive (normal), or ultrarapid metabolizers.
• Age: Enzyme activity is often reduced in newborns and the elderly, leading to slower drug clearance.
• Sex: Hormonal differences can influence the expression of certain metabolic enzymes.
• Liver disease: Conditions such as cirrhosis or hepatitis significantly reduce the liver's metabolic capacity.
• Drug-drug interactions: Some medications act as inhibitors (slowing down) or inducers (speeding up) of CYP enzymes, thereby affecting the metabolism of co-administered drugs.
• Diet: Certain foods, such as grapefruit juice, can inhibit CYP3A4 and increase the bioavailability of various medications.

Clinical Relevance

Understanding drug metabolism is essential for safe and effective pharmacotherapy. It provides the scientific basis for explaining:

• Why some patients experience stronger side effects or reduced drug efficacy.
• Why dose adjustments are necessary in patients with liver or kidney impairment.
• Why certain drug combinations can lead to dangerous interactions.
• Why pharmacogenetic testing can help personalize dosing for individual patients.

References

1. Brunton, L. L. et al. (Eds.) - Goodman & Gilman's: The Pharmacological Basis of Therapeutics. 13th Edition. McGraw-Hill Education, 2017.
2. Zanger, U. M. & Schwab, M. - Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics, 138(1):103-141, 2013. DOI: 10.1016/j.pharmthera.2012.12.007.
3. World Health Organization (WHO) - Introduction to Drug Utilization Research. WHO Press, Geneva, 2003.